Evidence map›Paper›PMID 40944846›Full record

ArticleRheumatology and therapy2025

Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.

Peter Youssef, Sabina Ciciriello, Talib Tahir, Joanna Leadbetter, Belinda Butcher, Miriam Calao, Nicole Walsh, Catherine O'Sullivan, Tegan Smith, Geoffrey Littlejohn

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Peter YoussefInstitute for Musculoskeletal Health at University of Sydney, Sydney, NSW, Australia.
Sabina CicirielloOPAL Rheumatology Ltd, Sydney, NSW, Australia.
Talib TahirCoburg Rheumatology Service, Coburg, VIC, Australia.
Joanna LeadbetterWriteSource Medical Pty Ltd, Lane Cove, NSW, Australia.
Belinda ButcherWriteSource Medical Pty Ltd, Lane Cove, NSW, Australia.
Miriam CalaoAbbVie Pty Ltd., Mascot, NSW, Australia.
Nicole WalshAbbVie Pty Ltd., Mascot, NSW, Australia.
Catherine O'SullivanOPAL Rheumatology Ltd, Sydney, NSW, Australia.
Tegan SmithOPAL Rheumatology Ltd, Sydney, NSW, Australia.
Geoffrey LittlejohnOPAL Rheumatology Ltd, Sydney, NSW, Australia. geoff.littlejohn@monash.edu.ORCID http://orcid.org/0000-0002-7896-055X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40944846
PMCPMC12638543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.